Abdominal Neoplasms - 350 Studies Found
| Completed |
: TRINOVA-1: A Study of AMG 386 or Placebo, in Combination With Weekly Paclitaxel Chemotherapy, as Treatment for Ovarian Cancer, Primary Peritoneal Cancer and Fallopian Tube Cancer :
|
| Completed |
: Saracatinib and Paclitaxel in Platinum-resistant Ovarian Cancer :
|
| Active, not recruiting |
: Phase II of Carbo/Pralatrexate in Rec. Platinum-Sensitive Ovarian, Fallopian or Primary Peritoneal Cancer :
|
| Completed |
: RO4929097 in Treating Patients With Recurrent and/or Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer :
|
| Active, not recruiting |
: Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer :
: |
| Active, not recruiting |
: Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer :
|
| Terminated |
: Neoadjuvant Therapy for Ovarian Cancer :
|
| Completed |
: Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast Cancer :
|
| Completed |
: Liposome-Encapsulated Doxorubicin Citrate With or Without Gemcitabine Hydrochloride in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer :
|
| Terminated |
: Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor :
|